Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes.
Anna Maria MilitelloGiulia OrsiAlessandro CavaliereMonica NigerAntonio AvalloneLisa SalvatoreGiampaolo TortoraIlario Giovanni RapposelliGuido GiordanoSilvia NoventaElisa GiommoniSilvia BozzarelliMarina MacchiniUmberto PerettiLetizia ProcaccioAlberto PucciniStefano CascinuCristina MontagnaMichele MilellaMichele ReniPublished in: Cancer chemotherapy and pharmacology (2023)
Pl-CT does not seem to be associated with a better outcome compared to AG chemotherapy in PDAC patients with BRCA 1/2 VUS.